KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.30 $2.95 Thursday, 25th Apr 2024 CLLS stock ended at $2.49. This is 0.400% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 5.85% from a day low at $2.47 to a day high of $2.61.
90 days $2.30 $3.13
52 weeks $0.96 $3.77

Historical Cellectis S.A. prices

Date Open High Low Close Volume
Oct 25, 2023 $1.02 $1.04 $0.99 $1.00 124 602
Oct 24, 2023 $1.12 $1.21 $0.99 $1.05 240 264
Oct 23, 2023 $1.21 $1.21 $1.17 $1.20 39 904
Oct 20, 2023 $1.30 $1.30 $1.21 $1.21 58 036
Oct 19, 2023 $1.33 $1.35 $1.30 $1.32 7 781
Oct 18, 2023 $1.32 $1.33 $1.31 $1.33 7 493
Oct 17, 2023 $1.33 $1.35 $1.33 $1.35 73 083
Oct 16, 2023 $1.40 $1.40 $1.35 $1.37 67 246
Oct 13, 2023 $1.45 $1.45 $1.38 $1.38 16 430
Oct 12, 2023 $1.41 $1.41 $1.36 $1.39 13 347
Oct 11, 2023 $1.45 $1.45 $1.40 $1.41 32 389
Oct 10, 2023 $1.46 $1.47 $1.41 $1.45 46 330
Oct 09, 2023 $1.44 $1.44 $1.40 $1.43 32 578
Oct 06, 2023 $1.48 $1.49 $1.44 $1.45 38 025
Oct 05, 2023 $1.43 $1.43 $1.38 $1.40 97 052
Oct 04, 2023 $1.54 $1.55 $1.37 $1.42 276 565
Oct 03, 2023 $1.50 $1.63 $1.47 $1.54 427 774
Oct 02, 2023 $1.58 $1.58 $1.50 $1.50 37 782
Sep 29, 2023 $1.58 $1.59 $1.58 $1.58 7 365
Sep 28, 2023 $1.58 $1.62 $1.58 $1.58 15 225
Sep 27, 2023 $1.60 $1.62 $1.58 $1.60 18 928
Sep 26, 2023 $1.60 $1.62 $1.58 $1.62 23 683
Sep 25, 2023 $1.69 $1.69 $1.60 $1.60 33 906
Sep 22, 2023 $1.65 $1.75 $1.65 $1.72 62 484
Sep 21, 2023 $1.65 $1.67 $1.60 $1.67 10 754
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT